Implanet Past Earnings Performance
Past criteria checks 0/6
Implanet has been growing earnings at an average annual rate of 12.6%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been declining at an average rate of 6.5% per year.
Key information
12.6%
Earnings growth rate
54.5%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | -6.5% |
| Return on equity | -189.3% |
| Net Margin | -62.2% |
| Next Earnings Update | 07 Mar 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Implanet makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 8 | -5 | 8 | 1 |
| 31 Mar 22 | 7 | -5 | 7 | 1 |
| 31 Dec 21 | 6 | -5 | 6 | 1 |
| 30 Sep 21 | 7 | -3 | 7 | 0 |
| 30 Jun 21 | 4 | -3 | 5 | 1 |
| 31 Mar 21 | 4 | -3 | 5 | 1 |
| 31 Dec 20 | 4 | -4 | 5 | 1 |
| 30 Sep 20 | 6 | -4 | 6 | 1 |
| 30 Jun 20 | 6 | -4 | 6 | 1 |
| 31 Mar 20 | 7 | -4 | 6 | 0 |
| 31 Dec 19 | 7 | -4 | 7 | 0 |
| 30 Sep 19 | 7 | -4 | 7 | 0 |
| 30 Jun 19 | 7 | -5 | 7 | 0 |
| 31 Mar 19 | 7 | -5 | 7 | 1 |
| 31 Dec 18 | 7 | -6 | 7 | 1 |
| 30 Sep 18 | 7 | -6 | 8 | 1 |
| 30 Jun 18 | 7 | -6 | 8 | 1 |
| 31 Mar 18 | 8 | -6 | 8 | 1 |
| 31 Dec 17 | 8 | -7 | 8 | 1 |
| 30 Sep 17 | 8 | -7 | 8 | 1 |
| 30 Jun 17 | 8 | -7 | 9 | 1 |
| 31 Mar 17 | 8 | -7 | 9 | 1 |
| 31 Dec 16 | 8 | -7 | 9 | 1 |
| 30 Sep 16 | 8 | -7 | 9 | 1 |
| 30 Jun 16 | 7 | -8 | 9 | 1 |
| 31 Mar 16 | 7 | -8 | 8 | 1 |
Quality Earnings: IM1 is currently unprofitable.
Growing Profit Margin: IM1 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IM1 is unprofitable, but has reduced losses over the past 5 years at a rate of 12.6% per year.
Accelerating Growth: Unable to compare IM1's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IM1 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: IM1 has a negative Return on Equity (-189.26%), as it is currently unprofitable.